Combinatorial docking and combinatorial chemistry: design of potent non-peptide thrombin inhibitors.
- 1 January 1999
- journal article
- Published by Springer Nature in Journal of Computer-Aided Molecular Design
- Vol. 13 (1) , 51-56
- https://doi.org/10.1023/a:1008040531766
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Viracept (Nelfinavir Mesylate, AG1343): A Potent, Orally Bioavailable Inhibitor of HIV-1 ProteaseJournal of Medicinal Chemistry, 1997
- Molecular Recognition of Protein−Ligand Complexes: Applications to Drug DesignChemical Reviews, 1997
- Stable Expression and Purification of a Secreted Human Recombinant Prethrombin-2 and Its Activation to ThrombinProtein Expression and Purification, 1997
- Towards the automatic design of synthetically accessible protein ligands: Peptides, amides and peptidomimeticsJournal of Computer-Aided Molecular Design, 1996
- Computational tools for structure-based ligand designProgress in Biophysics and Molecular Biology, 1996
- Design and Synthesis of Potent and Highly Selective Thrombin InhibitorsJournal of Medicinal Chemistry, 1994
- Current methods for site-directed structure generationJournal of Computer-Aided Molecular Design, 1994
- The development of a simple empirical scoring function to estimate the binding constant for a protein-ligand complex of known three-dimensional structureJournal of Computer-Aided Molecular Design, 1994
- The computer program LUDI: A new method for the de novo design of enzyme inhibitorsJournal of Computer-Aided Molecular Design, 1992
- Crystallographic analysis at 3.0-A resolution of the binding to human thrombin of four active site-directed inhibitors.Journal of Biological Chemistry, 1991